CAS: 103775-10-6; (3S)-2-[(2S)-2-[[(2S)-1-Ethoxy-1-Oxo-4-Phenylbutan-2-Yl]Amino]Propanoyl]-6,7-Dimethoxy-3,4-Dihydro-1H-Isoquinoline-3-Carboxylic Acid

该化合物是一种主要用于治疗高血压和心脏衰竭的抗抑制酶(ACE)抑制剂,主要用于治疗高血压和心脏衰竭,其作用是抑制将血管素I转换为血管素II,一种强大的血管收缩器,从而推动血管血管变异和减少血压.Moexipril 的化学配方是C20H26N2O5, 其独特的结构包括一种刺激衍生物,有助于其药理活动.Mexipril 通常以盐状盐的形式施用,加强其溶解性和生物利用率.该物质的特点是中度的亲脂性,允许在身体中有效吸收和分配.共同的副作用可能包括眩晕,咳嗽和高钾含量等.与其他ACE抑制剂一样,它与潜在的致畸效应相反,在怀孕时会受到抑制.

结构式图片

MSDS等安全信息

    合成工艺路线路线简述

      氢氯噻嗪,盐酸莫昔普利 反应生成莫西卜里
      参考文献:Reducing Er Stress In The Treatment Of Obesity And Diabetes
      标题:Reducing Er Stress In The Treatment Of Obesity And Diabetes
      摘要:内质网应激与肥胖有关.因此,减少或防止内质网应激的药物可用于治疗与肥胖相关的疾病,包括外周胰岛素抵抗,高血糖和2型糖尿病.已经显示出减少内质网应激并降低血糖水平的两种化合物包括4-苯基丁酸(pba),牛磺胆酸(tudca)和三甲胺氧化物(tmao).其他有用于减少内质网应激的化合物是化学分子伴侣,例如三甲胺氧化物和甘油.本发明提供了使用内质网应激减轻剂如pba,Tudca和tmao治疗患有肥胖,高血糖,2型糖尿病或胰岛素抵抗的受试者的方法.还提供了通过识别减少内质网应激标志物水平的药物筛选内质网应激减轻剂的方法.这些药物可用于治疗与肥胖相关的疾病的方法和制药组合物.

      海关参考信息

      专利信息


      专利号:US-9353057-B2
      优先权日:2003-12-30
      标 题:Synthesis of acyloxyalkyl carbamate prodrugs and intermediates thereof
      发明人:GALLOP MARK A; DAI XUEDONG; SCHEUERMAN RANDALL A; RAILLARD STEPHEN P; MANTHATI SURESH K; YAO FENMEI; PHAN THU; LUDWIKOW MARIA; PENG GE; BHAT SEEMA
      权利人:XENOPORT INC
      摘要:Methods for synthesis of 1-(acyloxy)-alkyl carbamates, particularly, the synthesis of 1-(acyloxy)-alkyl carbamate prodrugs of primary or secondary amine-containing drugs are described. Also described are methods for synthesis of 1-(acyloxy)-alkyl N-hydroxysuccinimidyl carbonates which are useful intermediates in the synthesis of 1-(acyloxy)-alkyl carbamates are also described.

      专利号:US-10973847-B2
      优先权日:2017-06-30
      标题 :Core-to-surface polymerization for the synthesis of star polymers and uses thereof
      发明人:JOHNSON JEREMIAH A; GOLDER MATTHEW R
      权利人:MASSACHUSETTS INST TECHNOLOGY
      摘要:Disclosed are methods, compositions, reagents, systems, and kits to prepare star polymers, as well as compositions and uses thereof. Various embodiments show that synthesis of these polymers contain low metal concentration to provide polymers for diverse biomedical applications including in vivo applications.

      专利号:US-8431712-B2
      优先权日:2004-02-09
      标 题 :Methods for the synthesis of pyridoxamine
      发明人:KHALIFAH RAJA G; KEILITZ ROLAND; KOELLNER CHRISTOPH; DEGENHARDT THORSTEN; BRAND STEPHEN ROBERT
      权利人:KHALIFAH RAJA G; KEILITZ ROLAND; KOELLNER CHRISTOPH; DEGENHARDT THORSTEN; BRAND STEPHEN ROBERT; NEPHROGENEX INC
      摘要:The invention provides non-oxidative methods for the large scale manufacture of pyridoxamine (I) (4-aminomethyl-3-hydroxy-5-hydroxymethyl-2-methylpyridine): n nand salts thereof.n nThe invention also provides intermediate compounds for the synthesis of pyridoxamine, as well as compositions and methods for the treatment and/or prevention of conditions associated with the formation of post-Amadori advanced glycation end-products.

      专利号:US-2008287407-A1
      优先权日:2003-12-10
      标题 :Nitric Oxide Releasing Pyruvate Compounds, Compositions and Methods of Use
      发明人:GARVEY DAVID S; FANG XINQIN; KHANAPURE SUBHASH P; RANATUNGA RAMANI R; WEY SHIOW-JYI
      权利人:NITROMED INC
      摘要:The invention describes novel nitrosated and/or nitrosylated pyruvate compounds and pharmaceutically acceptable salts thereof, and novel compositions comprising at least one nitrosated and/or nitrosylated pyruvate compound, and, optionally, at least one compound that donates, transfers or releases nitric oxide, stimulates endogenous synthesis of nitric oxide, elevates endogenous levels of endothelium-derived relaxing factor or is a substrate for nitric oxide synthase, and/or at least one therapeutic agent. The invention also provides novel compositions comprising at least one pyruvate compound and at least one compound that donates, transfers or releases nitric oxide, elevates endogenous levels of endothelium-derived relaxing factor, stimulates endogenous synthesis of nitric oxide or is a substrate for nitric oxide synthase and/or at least one therapeutic agent. The invention also provides novel kits comprising at least one pyruvate compound, that is optionally nitrosated and/or nitrosylated, and, optionally, at least one nitric oxide donor and/or at least one therapeutic agent. The invention also provides methods for treating diseases resulting from oxidative stress, diabetes, reperfusion injury following ischemia, preservation of tissues, organs, organ parts and/or limbs.

      专利号:US-2024368164-A1
      优先权日:2021-04-28
      标 题 :Purine nucleosides, their intermediates, and methods of preparation thereof
      发明人:RAVI RAMA SURESH; JACOBSON KENNETH A; POE RUSSELL BIRCH
      权利人:ASTROCYLE PHARMACEUTICALS INC; US HEALTH
      摘要:The present invention provides purine nucleoside analog compounds and methods of use thereof for treatment of certain injuries, disorders and conditions, for example brain injuries such as stroke or traumatic brain injuries. The present invention further provides methods of synthesizing such compounds, and intermediates useful in the synthesis of such compounds.

      专利号:US-7339065-B2
      优先权日:2003-07-21
      标题 :Design and synthesis of optimized ligands for PPAR
      发明人:AVERY MITCHELL A; PERSHADSINGH HARRIHAR A
      权利人:BETHESDA PHARMACEUTICALS INC; UNIV MISSISSIPPI
      摘要:This invention provides new chemical entities useful for treating a variety of clinical disorders including those that are influenced by the activity of peroxisome proliferator activated receptors (PPAR). The structures of the compounds and methods to design, make and use the compounds are provided. Compounds and methods for administering therapeutic compositions comprising the compounds in cases of the disease psoriasis are provided. An exemplary compound having the formula compound is 5adamantan-2-yl-pentanoic acid {2-[4-(2,4-dioxo-thiazolidin-5-yl-methyl)-phenoxy]-ethyl}-methyl-amide is provided.
      上海宽昊工贸有限公司
      ⚠️ 未注册 · 未认证企业
      ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
      数据来源于公开网络搜索,平台未作核实,请自行辨别。
      🏢敬请 企业认领
      🏬开设公司展台
      📢获取免费会员权益
      🎖️点亮专属注册企业标签
      📇展现公司完整信息 样本查看立即注册认领 →
      网址: http://www.kuanhao.com
      企业联系电话:021-66313386👤
      📞上海宽昊工贸有限公司 ⚠️参考联系方式
      联系人:吴华
      电话:021-66313386
      手机:13901628252
      传真:021-66313363
      邮箱:shkuanhao@163.com
      通信地址: 上海静安区江场西路299弄7号1702室
      邮编: 200436
      🆔 联系时候可告知是从"百琢研"平台获取的信息.
      ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

      地址:上海静安区江场西路299弄7号1702室
      ⚠️ 未注册 · 未认证企业
      注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
      ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
      第 1 / 1 页

      供应商参考报价(招募中)

      品牌试剂参考报价(招募中)

      📌 第三方产品分析报告

      ✅ COA系统入驻 | 共享模式

      合成参考文献


      摘要:Belousov IuB, Glezer MG, Tkhostova EB, Demidova MA. [Moexipril influence on quality of life in postmenopausal women with arterial hypertension]. Ter Arkh. 2005;77(10):75–8.
      📝 需求与反馈
      尽可能描述清楚需求与问题信息
      ×

      通知